Evidence map›Paper›PMID 18184875›Full record

ArticleAmerican journal of physiology. Cell physiology2008

K restriction inhibits protein phosphatase 2B (PP2B) and suppression of PP2B decreases ROMK channel activity in the CCD.

Yan Zhang, Dao-Hong Lin, Zhi-Jian Wang, Yan Jin, Baofeng Yang, Wen-Hui Wang

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Mechanistic target of rapamycin complex-1 plays a role in inhibiting kidney KAmerican journal of physiology. Renal physiology · 2026
    Article
  3. Role of calcineurin in regulating renal potassium (KActa physiologica (Oxford, England) · 2024
    Review
  4. Article
  5. Article
  6. Effects of reactive oxygen species on renal tubular transport.American journal of physiology. Renal physiology · 2019
    Review
  7. Review
  8. Review
  9. Article
  10. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe.Journal of the American Society of Nephrology : JASN · 2013
    Review
  11. NAD(P)H oxidase and renal epithelial ion transport.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yan ZhangDepartment of Pharmacology, Harbin Medical University, Harbin, China.
Dao-Hong Lin
Zhi-Jian Wang
Yan Jin
Baofeng Yang
Wen-Hui Wang
Harbin Medical University · CN

Funding

Vasoregulatory Function of CYP2E1-Derived EicosanoidsP01HL034300 · NHLBI · NEW YORK MEDICAL COLLEGE · PI JIANG, HOULI · 1985 to 2015
$33.4M
MODULATION OF K+ CHANNELS IN RENAL COLLECTING DUCTR01DK047402 · NIDDK · NEW YORK MEDICAL COLLEGE · PI WANG, WENHUI · 1999 to 2007
$2.3M
MODULATION OF K+ CHANNELS IN RENAL COLLECTING DUCTR29DK047402 · NIDDK · NEW YORK MEDICAL COLLEGE · PI WANG, WEN-HUI · 1994 to 1998
–
NHLBI NIH HHS P01 HL034300NIDDK NIH HHS DK-47402NIDDK NIH HHS R01 DK047402
6 · The paper itself

Abstract

We used Western blot analysis to examine the effect of dietary K intake on the expression of serine/threonine protein phosphatase in the kidney. K restriction significantly decreased the expression of catalytic subunit of protein phosphatase (PP)2B but increased the expression of PP2B regulatory subunit in both rat and mouse kidney. However, K depletion did not affect the expression of PP1 and PP2A. Treatment of M-1 cells, mouse cortical collecting duct (CCD) cells, or 293T cells with glucose oxidase (GO), which generates superoxide anions through glucose metabolism, mimicked the effect of K restriction on PP2B expression and significantly decreased expression of PP2B catalytic subunits. However, GO treatment increased expression of regulatory subunit of PP2B and had no effect on expression of PP1, PP2A, and protein tyrosine phosphatase 1D. Moreover, deletion of gp91-containing NADPH oxidase abolished the effect of K depletion on PP2B. Thus superoxide anions or related products may mediate the inhibitory effect of K restriction on the expression of PP2B catalytic subunit. We also used patch-clamp technique to study the effect of inhibiting PP2B on renal outer medullary K (ROMK) channels in the CCD. Application of cyclosporin A or FK506, inhibitors of PP2B, significantly decreased ROMK channels, and the effect of PP2B inhibitors was abolished by blocking p38 mitogen-activated protein kinase (MAPK) and ERK. Furthermore, Western blot demonstrated that inhibition of PP2B with cyclosporin A or small interfering RNA increased the phosphorylation of ERK and p38 MAPK. We conclude that K restriction suppresses the expression of PP2B catalytic subunits and that inhibition of PP2B decreases ROMK channel activity through stimulation of MAPK in the CCD.

Indexed as

Signal TransductionAnimalsBlotting, WesternCalcineurinCalcineurin InhibitorsCatalytic DomainCell LineCyclosporineDown-RegulationEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesFemaleGlucose OxidaseHumansKidney Tubules, CollectingMaleCalcineurinCalcineurin InhibitorsCybb protein, mouseCyclosporineEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesGlucose OxidaseKcnj1 protein, mouseKcnj1 protein, ratMembrane GlycoproteinsNADPH Oxidase 2NADPH Oxidasesp38 Mitogen-Activated Protein KinasesPotassium Channels, Inwardly RectifyingPotassium, DietaryProtein Phosphatase 1Protein Phosphatase 2RNA, Small InterferingSuperoxidesTacrolimus

Identifiers

PMID18184875
PMCPMC2734475
OpenAlexW2038198907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.